文献速递结核与非结核分枝杆菌

MTBVAC加强接种改善BCG对豚鼠结核的保护效果

Revaccination of Guinea Pigs With the Live Attenuated Mycobacterium tuberculosis Vaccine MTBVAC Improves BCG's Protection Against Tuberculosis.
PubMed 文献 · J Infect Dis · 2017-01-01

研究在豚鼠气溶胶感染模型中比较BCG与MTBVAC单独或不同初免-加强组合的免疫效果,以感染后4周细菌载量下降评价保护力。结果显示MTBVAC单剂免疫较BCG更持久,BCG初免后MTBVAC加强(长短间隔)均较BCG单独接种改善肺部保护,MTBVAC初免后短间隔BCG加强亦改善肺部保护,长间隔则与BCG单独接种相当。结论提示两疫苗组合可产生更强免疫,支持MTBVAC作为再接种策略。

要点

  • 豚鼠模型中MTBVAC单剂免疫的保护持续时间长于BCG单剂。
  • BCG初免后以MTBVAC加强,长短间隔均改善肺部保护。
  • MTBVAC初免后短间隔BCG加强改善肺部保护,长间隔与BCG相当。

核心结论

  • BCG与MTBVAC组合接种较BCG单独接种产生更强抗结核免疫,支持MTBVAC用于再接种策略。

研究设计与样本

  • 在豚鼠气溶胶感染结核分枝杆菌模型中比较BCG和MTBVAC单独或多种初免-加强组合。
  • 以感染后4周细菌载量下降评价疫苗效力。

主要发现

  • MTBVAC单剂免疫相关免疫较BCG单剂更持久。
  • BCG初免后MTBVAC加强(长间隔或短间隔)较BCG单独接种改善肺部效力。
  • MTBVAC初免后短间隔BCG加强较BCG单独接种改善肺部效力。
  • MTBVAC初免后长间隔BCG加强的保护与BCG单独接种相当。

临床怎么用

  • 提示MTBVAC可作为BCG接种人群的再接种候选策略,用于结核流行区已接种BCG者。
  • 初免-加强组合的间隔可能影响肺部保护效果,需在临床研究中进一步确定。

局限性

  • 证据来自豚鼠气溶胶感染模型,不能直接外推至人类。
  • 效力以感染后4周细菌载量下降评价,未报告长期保护数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The need for an effective vaccine against human tuberculosis has driven the development of different candidates and vaccination strategies. Novel live attenuated vaccines are being developed that promise greater safety and efficacy than BCG against tuberculosis. We combined BCG with the vaccine MTBVAC to evaluate whether the efficacy of either vaccine would be affected upon revaccination. METHODS: In a well-established guinea pig model of aerosol infection with Mycobacterium tuberculosis, BCG and MTBVAC delivered via various prime-boost combinations or alone were compared. Efficacy was determined by a reduction in bacterial load 4 weeks after challenge. RESULTS: Efficacy data suggests MTBVAC-associated immunity is longer lasting than that of BCG when given as a single dose. Long and short intervals between BCG prime and MTBVAC boost resulted in improved efficacy in lungs, compared with BCG given alone. A shorter interval between MTBVAC prime and BCG boost resulted in improved efficacy in lungs, compared with BCG given alone. A longer interval resulted in protection equivalent to that of BCG given alone. CONCLUSIONS: These data indicate that, rather than boosting the waning efficacy of BCG, a vaccination schedule involving a combination of the 2 vaccines yielded stronger immunity to M. tuberculosis infection. This work supports development of MTBVAC use as a revaccination strategy to improve on the effects of BCG in vaccinated people living in tuberculosis-endemic countries.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Clark S, Lanni F, Marinova D, et al. Revaccination of Guinea Pigs With the Live Attenuated Mycobacterium tuberculosis Vaccine MTBVAC Improves BCG's Protection Against Tuberculosis. J Infect Dis. 2017. PMID: 28329234. doi:10.1093/infdis/jix030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。